MADRID -- Remote screening yielded new cases of atrial fibrillation (Afib or AF) in the general population that otherwise would have gone undetected and untreated, according to the AMALFI trial in the ...
iRhythm Technologies today unveiled initial findings on the post-market and real-world performance of its Zio monitor, building on the devices previous generation of the long-term continuous ...
The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception. As doctors and hospitals slap its Zio patch monitors on more patients, the ...
iRhythm Technologies IRTC recently announced initial research findings on the post-market, real-world performance of the Zio monitor, IRTC’s next-generation Zio long-term continuous monitoring (LTCM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results